Category Archives: NuvaRing

Featured Stories

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

More Than 1,000 NuvaRing Lawsuits Set for Trial in October

More than 1,000 women have filed lawsuits in federal district court in Missouri against Merck & Co., the pharmaceutical company that manufactures the NuvaRing birth control device. The suits allege that NuvaRing caused blood clots, in some cases, fatal ones, … Continue reading

Posted in NuvaRing, Ortho Evra, Pharmaceuticals, Yaz / Yasmin |

Yaz, Yasmin and NuvaRing among Birth Control Methods with Higher Heart Risks

A new study has found that birth control methods that rely on a combination of the hormones estrogen and progestin may pose a higher risk of stroke and heart attacks compared to other hormonal methods.  The study, conducted by scientists … Continue reading

Posted in NuvaRing, Pharmaceuticals, Yaz / Yasmin | Tagged |

NuvaRing, Ortho Evra Pose Great Blood Clot Risk than Birth Control Pills

Using devices like NuvaRing or the Ortho Evra patch as a form of contraception presents a greater risk of serious injuries to women, namely blood clots, according to the results of a new study. BBC reports, a new study in … Continue reading

Posted in NuvaRing, Ortho Evra, Pharmaceuticals | Tagged |

Lawsuits Claiming NuvaRing Causes Blood Clots Continue to Build

NuvaRing is being linked to a series of thrombotic issues leading to serious health problems and litigation. The birth contol device can allegedly cause blood clots, some of which can be fatal. Manufacturers such as Merck & Co. are being … Continue reading

Posted in NuvaRing, Pharmaceuticals |

NuvaRing Lawsuit Judge Orders Hearing to Discuss Preliminary Plan for Settlement

Litigation surrounding the NuvaRing birth control device is moving ahead, with more women filing lawsuits alleging the contraceptive device caused serious injuries, including blood clots. Later this month, litigants in the NuvaRing multidistrict litigation currently underway in the U.S. District … Continue reading

Posted in NuvaRing, Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.